These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12954128)

  • 1. Internal radionuclide dosimetry: diagnostic and therapeutic nuclear medicine, occupational and environmental exposures. Differences and similarities.
    Mattsson S; Jacobsson L; Johansson L
    Cancer Biother Radiopharm; 2003 Jun; 18(3):421-4. PubMed ID: 12954128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
    Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
    J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
    Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
    Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear medicine dosimetry.
    Stabin M
    Phys Med Biol; 2006 Jul; 51(13):R187-202. PubMed ID: 16790903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
    Konijnenberg MW; Bijster M; Krenning EP; De Jong M
    J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation dosimetry for radioimmunotherapy. An overview of current capabilities and limitations.
    Fisher DR
    Cancer; 1994 Feb; 73(3 Suppl):905-11. PubMed ID: 8306278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal radionuclide radiation dosimetry: a review of basic concepts and recent developments.
    Zanzonico PB
    J Nucl Med; 2000 Feb; 41(2):297-308. PubMed ID: 10688115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine anatomic phantom for preclinical dosimetry in internal emitter therapy.
    Padilla L; Lee C; Milner R; Shahlaee A; Bolch WE
    J Nucl Med; 2008 Mar; 49(3):446-52. PubMed ID: 18287264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
    Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
    J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessments for high dose radionuclide therapy treatment planning.
    Fisher DR
    Radiat Prot Dosimetry; 2003; 105(1-4):581-6. PubMed ID: 14527031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation dosimetry in nuclear medicine.
    Stabin MG; Tagesson M; Thomas SR; Ljungberg M; Strand SE
    Appl Radiat Isot; 1999 Jan; 50(1):73-87. PubMed ID: 10028629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk.
    Stabin MG
    J Nucl Med; 2008 Sep; 49(9):1555-63. PubMed ID: 18765586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetry of internal emitters.
    Sgouros G
    J Nucl Med; 2005 Jan; 46 Suppl 1():18S-27S. PubMed ID: 15653648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.
    Pauwels S; Barone R; Walrand S; Borson-Chazot F; Valkema R; Kvols LK; Krenning EP; Jamar F
    J Nucl Med; 2005 Jan; 46 Suppl 1():92S-8S. PubMed ID: 15653657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
    Wessels BW; Konijnenberg MW; Dale RG; Breitz HB; Cremonesi M; Meredith RF; Green AJ; Bouchet LG; Brill AB; Bolch WE; Sgouros G; Thomas SR
    J Nucl Med; 2008 Nov; 49(11):1884-99. PubMed ID: 18927342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biokinetics of iodide in man: refinement of current ICRP dosimetry models.
    Johansson L; Leide-Svegborn S; Mattsson S; Nosslin B
    Cancer Biother Radiopharm; 2003 Jun; 18(3):445-50. PubMed ID: 12954132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIRD Pamphlet No 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney.
    Bouchet LG; Bolch WE; Blanco HP; Wessels BW; Siegel JA; Rajon DA; Clairand I; Sgouros G
    J Nucl Med; 2003 Jul; 44(7):1113-47. PubMed ID: 12843230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.
    Timmermand OV; Tran TA; Strand SE; Axelsson J
    J Nucl Med; 2015 Mar; 56(3):444-9. PubMed ID: 25655628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-specific internal radionuclide dosimetry.
    Tsougos I; Loudos G; Georgoulias P; Theodorou K; Kappas C
    Nucl Med Commun; 2010 Feb; 31(2):97-106. PubMed ID: 20032767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.